Come up with a name for your new list and we'll add to it:
Neoprospecta raised a round of funding on October 20, 2017. Investors include
Medical Innovation Summit.
Neoprospecta's laboratory analysis platform, Epiome, uses large-scale DNA sequencing over a wide geographical area and a large number of samples at a low cost. The results of DNA analysis are integrat…